In dystrophic muscles from mdx mice or DMD patients, we observed areas with strong sarcoplasmic immunoreactivity to RIPK3 antibody, which were not seen in mouse or human controls (Fig. 1f–h). This evidence concerns the gene RIPK3 and Duchenne muscular dystrophy.